Literature DB >> 4473998

Cellular hypersensitivity to uveal pigment confirmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.

H Hammer.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4473998      PMCID： PMC1215024          DOI： 10.1136/bjo.58.9.773

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  12 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  SEROLOGICAL STUDIES IN SYMPATHETIC OPHTHALMITIS.

Authors:  P V MILLS; W I SHEDDEN
Journal:  Br J Ophthalmol       Date:  1965-01       Impact factor: 4.638

3.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

4.  Cellular hypersensitivity in penetrating eye injuries.

Authors:  G E Marak; M S Aye; F P Alepa
Journal:  Invest Ophthalmol       Date:  1973-05

5.  Sympathetic ophthalmia and lymphocyte transformation.

Authors:  V G Wong; R Anderson; P J O'Brien
Journal:  Am J Ophthalmol       Date:  1971-11       Impact factor: 5.258

6.  Anti-adrenal, cellular hypersensitivity in Addison's disease.

Authors:  J Nerup; V Andersen; G Bendixen
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

7.  Lymphocyte transformation test in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.

Authors:  H Hammer
Journal:  Br J Ophthalmol       Date:  1971-12       Impact factor: 4.638

8.  Transformation of lymphocytes from patients with rheumatic fever by streptolysin S.

Authors:  I Gery; A Brand-Auraban; D Benezra; A Jacob; A M Davies
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

9.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

10.  In vitro detection of cellular hypersensitivity in man. Specific migration inhibition of white blood cells from brucella-positive persons.

Authors:  M Soborg
Journal:  Acta Med Scand       Date:  1967-08
View more
  12 in total

1.  Cellular hypersensitivity to lenticular protein in lens-induced uveitis.

Authors:  H Hammer; M Olah
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

2.  Hypersensitivity towards alpha-crystalline in the heterochromia syndrome.

Authors:  H Hammer; M Olah
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-10-17

3.  Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.

Authors:  S Otani; T Sakurai; K Yamamoto; T Fujita; Y Matsuzaki; Y Goto; Y Ando; S Suzuki; M Usui; M Takeuchi; Y Kawakami
Journal:  Br J Ophthalmol       Date:  2006-02-15       Impact factor: 4.638

4.  Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin's disease.

Authors:  S Y Chuah; A J Lyne; M W Dronfield
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Immunological investigations in post-traumatic granulomatous and non-granulomatous uveitis.

Authors:  A Rahi; G Morgan; I Levy; W Dinning
Journal:  Br J Ophthalmol       Date:  1978-10       Impact factor: 4.638

6.  Placoid pigment epitheliopathy and Harada's disease.

Authors:  B E Wright; A C Bird; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1978-09       Impact factor: 4.638

7.  [Immunological examinations in Vogt-Koyanagi-Harada disease (author's transl)].

Authors:  G Richard; B Dieckhues; G Jünemann
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

8.  Immunological studies in patients suffering from sympathetic ophthalmitis.

Authors:  H Hammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

9.  Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease.

Authors:  Sunao Sugita; Hiroshi Takase; Tatsushi Kawaguchi; Chikako Taguchi; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-01-26       Impact factor: 2.029

10.  Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.

Authors:  Jae Hee Lim; Yun Nah Lee; Young Seok Kim; Sang Gyune Kim; Seung Won Jeong; Jae Young Jang; Hong Soo Kim; Sae Hwan Lee; Tae Kwann Park
Journal:  Korean J Hepatol       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.